[Masking of HIV antigen by specific antibodies in a model experiment]

Voprosy Virusologii
|November 1, 1989
PubMed

Insights

A new competitive enzyme immunoassay (EIA) can detect human immunodeficiency virus (HIV) antigen. This test revealed that antibodies can mask HIV antigen, mimicking antigen clearance and suggesting immune response exhaustion.

Area of Science:

  • Immunology
  • Virology
  • Diagnostic assay development

Context:

  • Human immunodeficiency virus (HIV) infection diagnosis relies on detecting viral antigens and antibodies.
  • Competitive enzyme immunoassays (EIA) are established diagnostic tools.
  • Understanding antigen-antibody interactions is crucial for interpreting diagnostic test results.

Purpose:

  • To develop a sensitive competitive EIA for detecting HIV antigen.
  • To investigate the phenomenon of HIV antigen masking by antibodies in infected individuals.
  • To model antigen clearance in vitro and explore its implications for HIV antigenemia.

Summary:

  • A competitive EIA system capable of detecting HIV antigen at concentrations as low as 1 ng/ml was developed.
  • The study demonstrated that antibodies in sera from infected individuals can bind and mask HIV antigen's determinants.
  • This masking effect leads to "undetectability" of HIV antigen in the competitive EIA, serving as an in vitro model for antigen clearance when antibodies are in excess.

Impact:

  • The findings provide a model for understanding antigen "clearance" in the context of excess antibodies.
  • The results support the hypothesis that recurrent HIV antigenemia may result from the exhaustion of specific immune responses.
  • This research contributes to a deeper understanding of HIV pathogenesis and immune evasion strategies.

Related Concept Videos